Japan approved Optune Pax plus gemcitabine and nab-paclitaxel for unresectable locally advanced pancreatic cancer.
Advertisement
Advertisement
Trending on OncLive
1
Talquetamab Demonstrates Preserved Activity in MonumenTAL-1–Ineligible Patients With Relapsed/Refractory Myeloma
2
Berzosertib Plus Carboplatin Fails to Improve Responses in Pretreated mCRPC
3
Cisplatin-Releasing PRV111 Patch Elicits High pCR Rate in Early-Stage Oral Cancer
4
Unmet Clinical Needs in Biomarker-Guided Immune Checkpoint Inhibitor Treatment
5